Daniel Hirschhorn-Cymerman

2.3k total citations
22 papers, 1.7k citations indexed

About

Daniel Hirschhorn-Cymerman is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel Hirschhorn-Cymerman has authored 22 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 12 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel Hirschhorn-Cymerman's work include Immunotherapy and Immune Responses (21 papers), CAR-T cell therapy research (11 papers) and T-cell and B-cell Immunology (10 papers). Daniel Hirschhorn-Cymerman is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), CAR-T cell therapy research (11 papers) and T-cell and B-cell Immunology (10 papers). Daniel Hirschhorn-Cymerman collaborates with scholars based in United States, Japan and Slovakia. Daniel Hirschhorn-Cymerman's co-authors include Jedd D. Wolchok, Alan N. Houghton, Taha Merghoub, Alexander M. Lesokhin, Francesca Avogadri, Gabrielle Rizzuto, Shigehisa Kitano, Andrew D. Weinberg, David Schaer and Katherine S. Panageas and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Daniel Hirschhorn-Cymerman

21 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Hirschhorn-Cymerman United States	15	1.4k	979	272	87	74	22	1.7k
Aalok Kacha United States	6	1.2k 0.9×	834 0.9×	332 1.2×	81 0.9×	51 0.7×	9	1.5k
Marjolein Sluijter Netherlands	21	1.2k 0.9×	768 0.8×	364 1.3×	60 0.7×	119 1.6×	38	1.5k
Elixabet Bolaños Spain	19	972 0.7×	887 0.9×	290 1.1×	146 1.7×	80 1.1×	33	1.4k
Raquel Gomez-Eerland Netherlands	10	907 0.7×	913 0.9×	426 1.6×	142 1.6×	80 1.1×	14	1.4k
Sema Kurtuluş United States	13	1.3k 1.0×	970 1.0×	313 1.2×	48 0.6×	35 0.5×	23	1.7k
Laurent Derré Switzerland	24	1.4k 1.0×	827 0.8×	447 1.6×	60 0.7×	63 0.9×	58	1.8k
Teresa Rasalan United States	12	953 0.7×	742 0.8×	293 1.1×	77 0.9×	63 0.9×	17	1.2k
Sarah L. Buchan United Kingdom	18	829 0.6×	434 0.4×	392 1.4×	102 1.2×	81 1.1×	26	1.1k
Linda Pan United States	11	895 0.7×	522 0.5×	444 1.6×	106 1.2×	80 1.1×	23	1.1k
Kalijn F. Bol Netherlands	21	1.3k 0.9×	1.1k 1.1×	523 1.9×	79 0.9×	62 0.8×	42	1.7k

Countries citing papers authored by Daniel Hirschhorn-Cymerman

Since Specialization

Citations

This map shows the geographic impact of Daniel Hirschhorn-Cymerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Hirschhorn-Cymerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Hirschhorn-Cymerman more than expected).

Fields of papers citing papers by Daniel Hirschhorn-Cymerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Hirschhorn-Cymerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Hirschhorn-Cymerman. The network helps show where Daniel Hirschhorn-Cymerman may publish in the future.

Co-authorship network of co-authors of Daniel Hirschhorn-Cymerman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Hirschhorn-Cymerman. A scholar is included among the top collaborators of Daniel Hirschhorn-Cymerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Hirschhorn-Cymerman. Daniel Hirschhorn-Cymerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schad, Sara, Daniel Hirschhorn-Cymerman, Sadna Budhu, et al.. (2020). Phosphatidylserine targeting antibody enhances anti-tumor activity of adoptive cell therapies in a mouse melanoma model. The Journal of Immunology. 204(1_Supplement). 170.5–170.5.

Krebs, Simone, Lukas M. Carter, Daniel Hirschhorn-Cymerman, et al.. (2019). Immuno-PET imaging of activation markers on antigen-specific CD4 T cells in a mouse model of melanoma. 60. 609–609. 1 indexed citations

Zappasodi, Roberta, Sadna Budhu, Matthew D. Hellmann, et al.. (2018). Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity. Cancer Cell. 33(6). 1017–1032.e7. 113 indexed citations

González-Castro, Ana María, Mariana Manrique, Ekaterina Breous, et al.. (2016). Abstract 3204: INCAGN01949: an anti-OX40 agonist antibody with the potential to enhance tumor-specific T-cell responsiveness, while selectively depleting intratumoral regulatory T cells. Cancer Research. 76(14_Supplement). 3204–3204. 4 indexed citations

Khalil, Danny N., Sadna Budhu, Billel Gasmi, et al.. (2015). The New Era of Cancer Immunotherapy. Advances in cancer research. 128. 1–68. 34 indexed citations

Avogadri, Francesca, Roberta Zappasodi, Arvin Yang, et al.. (2014). Combination of Alphavirus Replicon Particle–Based Vaccination with Immunomodulatory Antibodies: Therapeutic Activity in the B16 Melanoma Mouse Model and Immune Correlates. Cancer Immunology Research. 2(5). 448–458. 36 indexed citations

Schaer, David, Daniel Hirschhorn-Cymerman, & Jedd D. Wolchok. (2014). Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy. Journal for ImmunoTherapy of Cancer. 2(1). 7–7. 93 indexed citations

Kitano, Shigehisa, Takemasa Tsuji, Daniel Hirschhorn-Cymerman, et al.. (2013). Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients. Cancer Immunology Research. 1(4). 235–244. 96 indexed citations

Melero, Ignacio, Daniel Hirschhorn-Cymerman, Aizea Morales‐Kastresana, Miguel F. Sanmamed, & Jedd D. Wolchok. (2013). Agonist Antibodies to TNFR Molecules That Costimulate T and NK Cells. Clinical Cancer Research. 19(5). 1044–1053. 124 indexed citations

10.

Hirschhorn-Cymerman, Daniel, Sadna Budhu, Shigehisa Kitano, et al.. (2012). Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype. The Journal of Experimental Medicine. 209(11). 2113–2126. 115 indexed citations

11.

Lesokhin, Alexander M., Tobias M. Hohl, Shigehisa Kitano, et al.. (2011). Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment. Cancer Research. 72(4). 876–886. 292 indexed citations

12.

Lesokhin, Alexander M., Tobias M. Hohl, Taha Merghoub, et al.. (2011). Monocytic CCR2+ Myeloid Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T Cell Infiltration Into the Tumor Microenvironment. Blood. 118(21). 2171–2171. 5 indexed citations

13.

Avogadri, Francesca, Taha Merghoub, Maureen F. Maughan, et al.. (2010). Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity. PLoS ONE. 5(9). e12670–e12670. 53 indexed citations

14.

Hirschhorn-Cymerman, Daniel & Miguel‐Angel Perales. (2010). Cytokine-FC Fusion Genes as Molecular Adjuvants for DNA Vaccines. Methods in molecular biology. 651. 131–155. 4 indexed citations

15.

Ruby, Carl E., Melissa A. Yates, Daniel Hirschhorn-Cymerman, et al.. (2009). Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right. The Journal of Immunology. 183(8). 4853–4857. 126 indexed citations

16.

Rizzuto, Gabrielle, Taha Merghoub, Daniel Hirschhorn-Cymerman, et al.. (2009). Self-antigen–specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response. The Journal of Experimental Medicine. 206(4). 849–866. 89 indexed citations

17.

Hirschhorn-Cymerman, Daniel, Gabrielle Rizzuto, Taha Merghoub, et al.. (2009). OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis. The Journal of Experimental Medicine. 206(5). 1103–1116. 169 indexed citations

18.

Na, Il‐Kang, Sydney X. Lu, Gabrielle L. Goldberg, et al.. (2008). The T Cell Cytolytic Molecules Fas Ligand and TRAIL, the Trafficking Molecules CCR9, β7 Integrin and PSGL-1, and the Immune Modulating Molecules OX40, CEACAM1, and CTLA4 Are Required for Thymic Graft-Versus-Host Disease. Blood. 112(11). 65–65. 9 indexed citations

19.

Ramirez‐Montagut, Teresa, Andrew Chow, Daniel Hirschhorn-Cymerman, et al.. (2006). Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity. The Journal of Immunology. 176(11). 6434–6442. 141 indexed citations

20.

Ferrone, Cristina R., Miguel‐Angel Perales, S. Goldberg, et al.. (2006). Adjuvanticity of Plasmid DNA Encoding Cytokines Fused to Immunoglobulin Fc Domains. Clinical Cancer Research. 12(18). 5511–5519. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact